Idecabtagene vicleucel (ide-cel) CAR T-cell therapy for relapsed and refractory multiple myeloma von Anderson, Jr, Larry D

Volltext

Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial von Voorhees, Peter M., Kaufman, Jonathan L., Laubach, Jacob, Sborov, Douglas W., Reeves, Brandi, Rodriguez, Cesar, Chari, Ajai, Silbermann, Rebecca, Costa, Luciano J., Anderson, Larry D., Nathwani, Nitya, Shah, Nina, Efebera, Yvonne A., Holstein, Sarah A., Costello, Caitlin, Jakubowiak, Andrzej, Wildes, Tanya M., Orlowski, Robert Z., Shain, Kenneth H., Cowan, Andrew J., Murphy, Sean, Lutska, Yana, Pei, Huiling, Ukropec, Jon, Vermeulen, Jessica, de Boer, Carla, Hoehn, Daniela, Lin, Thomas S., Richardson, Paul G.

Volltext

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma von Munshi, Nikhil C, Anderson, Larry D, Shah, Nina, Madduri, Deepu, Berdeja, Jesús, Lonial, Sagar, Raje, Noopur, Lin, Yi, Siegel, David, Oriol, Albert, Moreau, Philippe, Yakoub-Agha, Ibrahim, Delforge, Michel, Cavo, Michele, Einsele, Hermann, Goldschmidt, Hartmut, Weisel, Katja, Rambaldi, Alessandro, Reece, Donna, Petrocca, Fabio, Massaro, Monica, Connarn, Jamie N, Kaiser, Shari, Patel, Payal, Huang, Liping, Campbell, Timothy B, Hege, Kristen, San-Miguel, Jesús

Volltext

More key players in the game for myeloma prognosis and therapy von Anderson, Larry D.

Volltext

Continued Refinement of the Treatment for Light-Chain Cardiac Amyloidosis von Grodin, Justin L., Anderson, Larry D., Kansagra, Ankit

Volltext

Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/ refractory multiple myeloma: US Myeloma Immunotherapy Consortium... von Hashmi, Hamza, Hansen, Doris K, Peres, Lauren C, Puglianini, Omar Castaneda, Freeman, Ciara, De Avila, Gabriel, Sidana, Surbhi, Shune, Leyla, Sborov, Douglas W, Davis, James, Wagner, Charlotte, Kocoglu, Mehmet H, Atrash, Shebli, Voorhees, Peter, Simmons, Gary, Ferreri, Christopher, Kalariya, Nilesh, Anderson, Jr, Larry D, Afrough, Aimaz, Dima, Danai, Khouri, Jack, McGuirk, Joseph, Locke, Fred, Baz, Rachid, Patel, Krina K, Alsina, Melissa

Volltext

Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial von Trudel, Suzanne, Lendvai, Nikoletta, Popat, Rakesh, Voorhees, Peter M, Reeves, Brandi, Libby, Edward N, Richardson, Paul G, Anderson, Larry D, Sutherland, Heather J, Yong, Kwee, Hoos, Axel, Gorczyca, Michele M, Lahiri, Soumi, He, Zangdong, Austin, Daren J, Opalinska, Joanna B, Cohen, Adam D

Volltext

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma von Richardson, Paul G., Jacobus, Susanna J., Weller, Edie A., Hassoun, Hani, Lonial, Sagar, Raje, Noopur S., Medvedova, Eva, McCarthy, Philip L., Libby, Edward N., Voorhees, Peter M., Orlowski, Robert Z., Anderson, Larry D., Zonder, Jeffrey A., Milner, Carter P., Gasparetto, Cristina, Agha, Mounzer E., Khan, Abdullah M., Hurd, David D., Gowin, Krisstina, Kamble, Rammurti T., Jagannath, Sundar, Nathwani, Nitya, Alsina, Melissa, Cornell, R. Frank, Hashmi, Hamza, Campagnaro, Erica L., Andreescu, Astrid C., Gentile, Teresa, Liedtke, Michaela, Godby, Kelly N., Cohen, Adam D., Openshaw, Thomas H., Pasquini, Marcelo C., Giralt, Sergio A., Kaufman, Jonathan L., Yee, Andrew J., Scott, Emma, Torka, Pallawi, Foley, Amy, Fulciniti, Mariateresa, Hebert, Kyle, Samur, Mehmet K., Masone, Kelly, Maglio, Michelle E., Zeytoonjian, Andrea A., Nadeem, Omar, Schlossman, Robert L., Laubach, Jacob P., Paba-Prada, Claudia, Ghobrial, Irene M., Perrot, Aurore, Moreau, Philippe, Avet-Loiseau, Hervé, Attal, Michel, Anderson, Kenneth C., Munshi, Nikhil C.

Volltext

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse von Dimopoulos, Meletios, Weisel, Katja, Moreau, Philippe, Anderson, Larry D., White, Darrell, San-Miguel, Jesus, Sonneveld, Pieter, Engelhardt, Monika, Jenner, Matthew, Corso, Alessandro, Dürig, Jan, Pavic, Michel, Salomo, Morten, Casal, Eva, Srinivasan, Shankar, Yu, Xin, Nguyen, Tuong Vi, Biyukov, Tsvetan, Peluso, Teresa, Richardson, Paul

Volltext

Editorial: T-cell directed therapies in multiple myeloma von Richter, Joshua, Anderson, Jr, Larry D, Ramasamy, Karthik, Rossi, Adriana

Volltext

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phas... von Grosicki, Sebastian, Simonova, Maryana, Spicka, Ivan, Pour, Ludek, Kriachok, Iryrna, Gavriatopoulou, Maria, Pylypenko, Halyna, Auner, Holger W, Leleu, Xavier, Doronin, Vadim, Usenko, Ganna, Bahlis, Nizar J, Hajek, Roman, Benjamin, Reuben, Dolai, Tuphan K, Sinha, Dinesh K, Venner, Christopher P, Garg, Mamta, Gironella, Mercedes, Jurczyszyn, Artur, Robak, Pawel, Galli, Monica, Wallington-Beddoe, Craig, Radinoff, Atanas, Salogub, Galina, Stevens, Don A, Basu, Supratik, Liberati, Anna M, Quach, Hang, Goranova-Marinova, Vesselina S, Bila, Jelena, Katodritou, Eirini, Oliynyk, Hanna, Korenkova, Sybiryna, Kumar, Jeevan, Jagannath, Sundar, Moreau, Phillipe, Levy, Moshe, White, Darrell, Gatt, Moshe E, Facon, Thierry, Mateos, Maria V, Cavo, Michele, Reece, Donna, Anderson, Larry D, Saint-Martin, Jean-Richard, Jeha, Jacqueline, Joshi, Anita A, Chai, Yi, Li, Lingling, Peddagali, Vishnuvardhan, Arazy, Melina, Shah, Jatin, Shacham, Sharon, Kauffman, Michael G, Dimopoulos, Meletios A, Richardson, Paul G, Delimpasi, Sosana

Volltext

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy von Ferreri, Christopher J., Hildebrandt, Michelle A. T., Hashmi, Hamza, Shune, Leyla O., McGuirk, Joseph P., Sborov, Douglas W., Wagner, Charlotte B., Kocoglu, M. Hakan, Rapoport, Aaron, Atrash, Shebli, Voorhees, Peter M., Khouri, Jack, Dima, Danai, Afrough, Aimaz, Kaur, Gurbakhash, Anderson, Larry D., Simmons, Gary, Davis, James A., Kalariya, Nilesh, Peres, Lauren C., Lin, Yi, Janakiram, Murali, Nadeem, Omar, Alsina, Melissa, Locke, Frederick L., Sidana, Surbhi, Hansen, Doris K., Patel, Krina K., Castaneda Puglianini, Omar Alexis

Volltext

KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma von Jagannath, Sundar, Lin, Yi, Goldschmidt, Hartmut, Reece, Donna, Nooka, Ajay, Senin, Alicia, Rodriguez-Otero, Paula, Powles, Ray, Matsue, Kosei, Shah, Nina, Anderson, Larry D., Streetly, Matthew, Wilson, Kimberly, Le, Hoa Van, Swern, Arlene S., Agarwal, Amit, Siegel, David S.

Volltext

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis von Hoff, Fieke W., Banerjee, Rahul, Khan, Adeel M., McCaughan, Georgia, Wang, Bo, Wang, Xiaoliang, Roose, James, Anderson, Larry D., Cowan, Andrew J., Rajkumar, S. Vincent, Kaur, Gurbakhash

Volltext

Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma--A Unique Entity: A Report of Two Cases With Low-Level Bone Marrow Involvement and Review of the Literature von Germans, Sharon Koorse, Kulak, Ozlem, Koduru, Prasad, Oliver, Dwight, Gagan, Jeffery, Patel, Prapti, Anderson, Larry D., Jr, Fuda, Franklin S, Chen, Weina, Jaso, Jesse Manuel

Volltext

Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel von Zanwar, Saurabh, Sidana, Surbhi, Shune, Leyla, Puglianini, Omar Castaneda, Pasvolsky, Oren, Gonzalez, Rebecca, Dima, Danai, Afrough, Aimaz, Kaur, Gurbakhash, Davis, James A, Herr, Megan, Hashmi, Hamza, Forsberg, Peter, Sborov, Douglas, Anderson, Jr, Larry D, McGuirk, Joseph P, Wagner, Charlotte, Lieberman-Cribbin, Alex, Rossi, Adriana, Freeman, Ciara L, Locke, Frederick L, Richard, Shambavi, Khouri, Jack, Lin, Yi, Patel, Krina K, Kumar, Shaji K, Hansen, Doris K

Volltext

Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where Are We Now and What Is Needed to Move Chimeric Antigen Receptor T Cells Forward to Earlier Lines of Therapy? Expert Pane... von Anderson, Larry D., Dhakal, Binod, Jain, Tania, Oluwole, Olalekan O., Shah, Gunjan L., Sidana, Surbhi, Perales, Miguel-Angel, Pasquini, Marcelo C.

Volltext

Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians von Banerjee, Rahul, Wang, Bo, Anderson, Larry D., McCaughan, Georgia, Mehra, Nikita, Cowan, Andrew J., Rajkumar, S. Vincent, Kaur, Gurbakhash

Volltext

Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience von Dima, Danai, Davis, James A., Ahmed, Nausheen, Jia, Xuefei, Sannareddy, Aishwarya, Shaikh, Hira, Shune, Leyla, Kaur, Gurbakhash, Khouri, Jack, Afrough, Aimaz, Strouse, Christopher, Lochner, Jonathan, Mahmoudjafari, Zahra, Raza, Shahzad, Valent, Jason, Anderson, Larry D., Anwer, Faiz, Abdallah, Al-Ola, Hashmi, Hamza

Volltext

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium von Afrough, Aimaz, Hashmi, Hamza, Hansen, Doris K., Sidana, Surbhi, Ahn, Chul, Peres, Lauren C., Dima, Danai, Freeman, Ciara L., Puglianini, Omar Castaneda, Kocoglu, Mehmet H., Atrash, Shebli, Voorhees, Peter M., Shune, Leyla, McGuirk, Joseph P., Simmons, Gary, Sborov, Douglas W., Davis, James A., Kaur, Gurbakhash, Sannareddy, Aishwarya, Ferreri, Christopher J., Gaballa, Mahmoud R., Goldsmith, Scott, Nadeem, Omar, Midha, Shonali, Wagner, Charlotte B., Locke, Frederick L., Patel, Krina K., Khouri, Jack, Anderson, Larry D., Lin, Yi

Volltext